Table 6 Publications investigating EVs from mesenchymal stem cells.
Ref. | PM | Size | Injury model | Main effector | EV marker |
|---|---|---|---|---|---|
Feng et al.10 | UC/Precipitation | 30–120 nm | MI | miR-22 | CD63 |
X. Wang et al.9 | UC, sucrose gradient | 10–100 nm | Sepsis/Inflammation | miR-223 | CD81, CD63 |
Teng et al.44 | Precipitation | 50–100 nm | MI | NSI | CD63 |
Zhang et al.46 | Precipitation | 11–98 nm | MI | NS | CD63, GAPDH |
Zhao et al.23 | UC, sucrose cushion, ultrafiltration | 20–85 nm | In vitro hypoxia, MI | NSI | CD9, CD63 |
Kang et al.36 | Precipitation | 40–90 nm | MI | CXCR4 | CD9, CD63 |
Yu et al.41 | Precipitation | ≈100 m* | NSI | (miR-221) | CD9, CD63, HSP70 |
Yu et al.42 | Precipitation | ≈100 nm | In vitro hypoxia, MI | miR-19a | CD9, CD63, HSP70 |
Lai et al.20 | Size exclusion fractionation (UC sucrose gradient, Immunoprecipitation) | 55–65 nm | I/R-injury | NSI | CD9, CD81, Alix |
Arslan et al.50 | Ultrafiltration, Chromatography | NSI | I/R-injury | NSI | NSI |
Shi et al.48 | Precipitation | 30–100 nm | H2O2 | miR-21 | CD9, CD63, HSP70 |
